SONEAS Chemicals Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
SONEAS Chemicals Ltd. - overview
Established
1996
Location
Budapest, -, Hungary
Primary Industry
Chemicals
About
SONEAS Chemicals Ltd. is a contract development and manufacturing organization (CDMO) specializing in providing advanced chemical services for pharmaceutical and biotech sectors across Europe and North America. Founded in 1996 and headquartered in Budapest, Hungary, SONEAS Chemicals Ltd. operates within the European chemical industry.
The company was acquired by Uquifa SA in May 2018, although specific financial terms were not disclosed. SONEAS has completed two deals to date. SONEAS Chemicals Ltd. offers a wide range of services tailored for pharmaceutical, biotech, and chemical companies.
These include discovery services, process research and development (R&D), and GMP compliant large-scale manufacturing. Their facilities are equipped for various product development stages, servicing clients engaged in preclinical and clinical trials while adhering to stringent quality standards. In the most recent fiscal year of 2023, SONEAS Chemicals Ltd. reported a revenue of USD 52.
92 mn and an EBITDA of USD 9. 72 mn, mainly derived from B2B transactions with pharmaceutical and biotech companies requiring specialized chemical services. Moving forward, SONEAS Chemicals Ltd. aims to expand its product offerings and enter new geographical markets.
The company plans to use the insights gained from its recent acquisition to streamline operations and enhance service delivery. Specific upcoming products are currently under design, with targeted expansions in regions across Europe and North America expected to commence by the end of 2024.
Primary Industry
Chemicals
Sub Industries
Commodity Chemicals, Medicinal Chemicals & Botanicals
Website
www.soneas.com
Company Stage
Acquired
Total Amount Raised
Subscriber access only
SONEAS Chemicals Ltd. - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | 460,787,000 | 1,031,015,000 | 1,180,076,000 | 1,329,300,000 | 1,699,020,000 | 1,629,617,000 | 3,388,859,000 | 3,076,108,000 | 5,261,699,000 | 10,187,064,000 | 15,835,445,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | 123.8% | 14.5% | 12.6% | 27.8% | (4.1%) | 108.0% | (9.2%) | 71.1% | 93.6% | 55.4% | - | - | - |
| EBITDA (USD) | - | - | 18,200,000 | 79,185,000 | 56,038,000 | 177,984,000 | 180,277,000 | 386,408,000 | 723,441,000 | 560,692,000 | 696,926,000 | 2,134,537,000 | 3,239,677,000 | - | - | - |
| Operating Income (USD) | - | - | 14,108,000 | 54,761,000 | 10,937,000 | 13,802,000 | (12,236,000) | 197,002,000 | 477,214,000 | 338,768,000 | 398,578,000 | 1,620,324,000 | 2,598,806,000 | - | - | - |
| Operating Margin | - | - | 3.1% | 5.3% | 0.9% | 1.0% | (0.7%) | 12.1% | 14.1% | 11.0% | 7.6% | 15.9% | 16.4% | - | - | - |
| % EBITDA Margin | - | - | 3.9% | 7.7% | 4.7% | 13.4% | 10.6% | 23.7% | 21.3% | 18.2% | 13.2% | 21.0% | 20.5% | - | - | - |
| NET Income (USD) | - | - | 1,854,000 | 1,266,000 | 1,661,000 | (115,450,000) | (114,036,000) | 157,019,000 | (267,800,000) | 148,566,000 | (2,459,000) | 1,498,436,000 | 2,161,075,000 | - | - | - |
| % Net Margin | - | - | 0.4% | 0.1% | 0.1% | (8.7%) | (6.7%) | 9.6% | (7.9%) | 4.8% | (0.0%) | 14.7% | 13.6% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.